All posts by: Michael Zand

About Michael Zand

Aduro Biotech Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer’s 32nd Annual … – GlobeNewswire (press release)

Continue reading

2017-10-09 NEWS

Aduro Biotech Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer’s 32nd Annual …
GlobeNewswire (press release)
BERKELEY, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced data presentations relating to its technology platforms to be given …

Continue reading

2017-10-09 NEWS

Business Insider

Meet the 30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine
Business Insider
Tim Lu, associate professor of biological engineering, electrical engineering, and computer science at MIT, runs the Synthetic Biology Group at MIT, where he’s worked to develop synthetic biology that’s programmed to be more precise therapies.

and more »

Continue reading

2017-10-09 NEWS

AZ files immunotherapy Imfinzi in Europe – PharmaTimes
PharmaTimes
AstraZeneca has submitted the first marketing application in Europe for its immunotherapy Imfinzi, seeking approval for the drug’s use to treat a subset of patients …

and more »

Continue reading

2017-10-09 NEWS

STAT

Spark’s novel gene therapy for blindness is racing to a historic date with the FDA
STAT
On Thursday, a committee of experts invited by the FDA will meet outside Washington D.C. to review an experimental gene therapy from Spark Therapeutics (ONCE 1). Barring unexpected surprises, the experts will advise the FDA to approve the one-time shot …